3-(4-(Difluoromethyl)-2-methyl-6-oxo-2H-pyrazolo[3,4-b]pyridin-7(6H)-yl)propanoic acid

Catalog No. :
ACNLXI052
CAS No. :
1018165-34-8
Molecular Formula :
C11H11F2N3O3
Molecular Weight :
271.22

IUPAC Name:3-(4-(difluoromethyl)-2-methyl-6-oxo-2,6-dihydro-7H-pyrazolo[3,4-b]pyridin-7-yl)propanoic acid

3-(4-(Difluoromethyl)-2-methyl-6-oxo-2H-pyrazolo[3,4-b]pyridin-7(6H)-yl)propanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$423.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(4-(Difluoromethyl)-2-methyl-6-oxo-2H-pyrazolo[3,4-b]pyridin-7(6H)-yl)propanoic acid
IUPAC Name3-(4-(difluoromethyl)-2-methyl-6-oxo-2,6-dihydro-7H-pyrazolo[3,4-b]pyridin-7-yl)propanoic acid
MDL No.MFCD09834306
Molecular FormulaC11H11F2N3O3
Molecular Weight271.22
SMILESO=C(O)CCN(C1=NN(C)C=C1C(C(F)F)=C2)C2=O
InChI KeyZRCVVQNURQMNJS-UHFFFAOYSA-N
Synonym3-[4-(Difluoromethyl)-2-methyl-6-oxo-2,6-dihydro-7H-pyrazolo[3,4-b]pyridin-7-yl]propanoic acid;7H-Pyrazolo[3,4-b]pyridine-7-propanoic acid, 4-(difluoromethyl)-2,6-dihydro-2-methyl-6-oxo-;3-[4-(Difluoromethyl)-2-methyl-6-oxo-2H,6H,7H-pyrazolo[3,4-b]pyridin-7-yl]propanoic acid
CAS No.1018165-34-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACNLXI052 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNLXI052 route product structure diagram
    ACNLXI0521018165-34-8
Inquiry

2. ACNLXI052 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNLXI052 route product structure diagram
    ACNLXI0521018165-34-8
Inquiry

Comments (0)